You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬邦德(002082.SZ):目前銀杏葉滴丸OTC渠道及第三終端有所增長
格隆匯 11-22 15:27

格隆匯11月22日丨萬邦德(002082.SZ)在投資者活動上表示,公司業績浮動主要受產品集中帶量採購的影響,主要是公司核心產品銀杏葉滴丸中標帶量採購後,產品價格較大幅度的下調,下降幅度約54%,影響了公司營收和利潤情況。隨着集採政策實施區域逐漸擴大和常態化,醫療、醫藥政策企穩後,公司積極調整營銷策略,消化帶量採購帶來的側壓,目前銀杏葉滴丸OTC渠道及第三終端有所增長、間苯三酚注射劑、溴己新產品等產品增長。醫療器械板塊高分子產品中標集採後,市場份額進一步擴大,使銷售額增加,營業收入較上年大幅增長;同時,公司優化南非運營體系,在診斷影像、手術器械和患者監測系統等各種醫療器械方面,努力提升市場佔有率,實現了南非板塊營收的進一步增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account